Robert C. Carlisle

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications

Evidence of endothelial anergy and T-cell exclusion in microsatellite stable colorectal liver metastases revealed through human hemi-liver perfusion and spatial transcriptomics.

Evidence of endothelial anergy and T-cell exclusion in microsatellite stable colorectal liver metastases revealed through human hemi-liver perfusion and spatial transcriptomics.

Journal: Molecular cancer
Published: March 11, 2026

En-risk to de-risk: An iterative human factors framework for scale development in emerging technologies.

En-risk to de-risk: An iterative human factors framework for scale development in emerging technologies.

Journal: JAAD international
Published: January 22, 2026

Discriminative Cut-Offs, Concurrent Criterion Validity, and Test-Retest Reliability of the Oxford Vaccine Hesitancy Scale.

Discriminative Cut-Offs, Concurrent Criterion Validity, and Test-Retest Reliability of the Oxford Vaccine Hesitancy Scale.

Journal: Vaccines
Published: October 25, 2025

Public attitudes towards intranasal and ultrasound mediated vaccine delivery: A cross-sectional study in the United Kingdom and United States.

Public attitudes towards intranasal and ultrasound mediated vaccine delivery: A cross-sectional study in the United Kingdom and United States.

Journal: Vaccine
Published: July 22, 2025

Normothermic perfusion of human livers for profiling lentiviral vector pharmacokinetics and transduction.

Normothermic perfusion of human livers for profiling lentiviral vector pharmacokinetics and transduction.

Journal: Molecular therapy. Advances
Published: July 07, 2025

Use of resazurin-based metabolic assays as a continuous measure of viability in three-dimensional (3D) in vitro cell culture: A study with Presto Blue™.

Use of resazurin-based metabolic assays as a continuous measure of viability in three-dimensional (3D) in vitro cell culture: A study with Presto Blue™.

Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: March 10, 2025

Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies.

Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies.

Journal: Human vaccines & immunotherapeutics
Published: March 03, 2025

Progress in Gene Therapy for Hereditary Tyrosinemia Type 1.

Progress in Gene Therapy for Hereditary Tyrosinemia Type 1.

Journal: Pharmaceutics
Published: February 10, 2025

Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy.

Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy.

Journal: BMJ open
Published: October 09, 2024

The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitudes and expectations in the general public.

The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitudes and expectations in the general public.

Journal: BMJ open
Published: December 14, 2023

Sonosensitive Cavitation Nuclei-A Customisable Platform Technology for Enhanced Therapeutic Delivery.

Sonosensitive Cavitation Nuclei-A Customisable Platform Technology for Enhanced Therapeutic Delivery.

Journal: Molecules (Basel, Switzerland)
Published: October 06, 2023

Cavitation-Mediated Immunomodulation and Its Use with Checkpoint Inhibitors.

Cavitation-Mediated Immunomodulation and Its Use with Checkpoint Inhibitors.

Journal: Pharmaceutics
Published: June 15, 2023
Showing 1-12 of 60

Last Updated: 09/26/2026